Bionor Immuno AS: Clinical Trials

6 trials sponsored by Bionor Immuno AS, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

6 completed. 6 Phase 2, 4 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 6
Phase 1	4	Completed 4

Follow Bionor Immuno AS: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir Romidepsin, Vacc-4x, rhuGM-CSF - HIV I Infection	Phase 1 / Phase 2	Completed	Bionor Immuno AS	26	2014-03-01	2017-03-01
Re-boosting of HIV-1 Infected Subjects With Vacc-4x Vacc-4x - HIV-1 Infection	Phase 2	Completed	Bionor Immuno AS	33	2012-12-01	2017-03-06
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART Vacc-C5/GM-CSF, Vacc-C5/Alhydrogel - HIV-1 Infection	Phase 1 / Phase 2	Completed	Bionor Immuno AS	36	2012-09-01	2014-01-14
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) Lenalidomide, Lenalidomide placebo, Vacc-4X - HIV-1 Infection	Phase 1 / Phase 2	Completed	Bionor Immuno AS	36	2012-09-01	2017-03-08
Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant Vacc-4x low dose, Vacc-4x medium dose, Vacc-4x high dose - HIV Infection	Phase 1 / Phase 2	Completed	Oslo University Hospital	24	2011-11-01	2012-06-20
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV Vacc-4x, Sterile water - HIV I Infection	Phase 2	Completed	Bionor Immuno AS	137	2008-08-01	2017-02-23

Conditions studied

Interventions

Countries

Top investigators

Results publications